ORABODY Trademark

Trademark Overview


On Wednesday, August 24, 2016, a trademark application was filed for ORABODY with the United States Patent and Trademark Office. The USPTO has given the ORABODY trademark a serial number of 87150012. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Wednesday, November 15, 2023. This trademark is owned by Landing Biotech, Inc.. The ORABODY trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bact...
orabody

General Information


Serial Number87150012
Word MarkORABODY
Filing DateWednesday, August 24, 2016
Status701 - SECTION 8 - ACCEPTED
Status DateWednesday, November 15, 2023
Registration Number5336498
Registration DateTuesday, November 14, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2017

Trademark Statements


Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the prevention and treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 30, 2016
Primary Code005
First Use Anywhere DateMonday, December 28, 2015
First Use In Commerce DateMonday, August 1, 2016

Trademark Owner History


Party NameLanding Biotech, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressVacaville, CA 95688

Party NameLanding Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewton, MA 02466

Party NameLanding Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewton, MA 02466

Trademark Events


Event DateEvent Description
Wednesday, November 15, 2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Wednesday, November 15, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, November 9, 2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, November 21, 2022OFFICE ACTION ISSUED POU1
Sunday, November 20, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 15, 2022TEAS SECTION 8 RECEIVED
Monday, November 14, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 14, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, October 12, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 11, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 18, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, September 1, 2017USE AMENDMENT FILED
Monday, September 18, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 1, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, March 8, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, December 4, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, December 4, 2016ASSIGNED TO EXAMINER
Tuesday, August 30, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 27, 2016NEW APPLICATION ENTERED